本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Rhythm Pharmaceuticals Inc.

104.71
+2.512.46%
盤後104.710.00000.00%19:30 EDT
成交量:57.37萬
成交額:6,014.22萬
市值:72.10億
市盈率:-33.59
高:106.57
開:102.96
低:102.25
收:102.20
52周最高:122.20
52周最低:74.50
股本:6,885.21萬
流通股本:6,539.41萬
量比:1.33
換手率:0.88%
股息:- -
股息率:- -
每股收益(TTM):-3.1172
每股收益(LYR):-3.1100
淨資產收益率:-117.04%
總資產收益率:-30.96%
市淨率:70.01
市盈率(LYR):-33.67

資料載入中...

2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/05

重要事件披露

Form 8-K - Current report
2024/09/19

重要事件披露

Form 8-K - Current report
2024/09/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/15

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]